Drugs / ACORAFLOXACIN
ACORAFLOXACIN
also known as
JNJ-32729463 · ACORAFLOXACIN HYDROCHLORIDE · Acorafloxacine · Acorafloxacino · JNJ-32729463-AAA · JNJ-32729463-AAC · JNJ-Q2 · Jnj-q2 hydrochloride
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01198626 | Oct 2010 → Oct 2011 | bacterial pneumonia | Furiex Pharmaceuticals, Inc | Terminated | No outcome recorded |
| Phase 2 | NCT01128530 | Jun → Dec 2010 | — | Furiex Pharmaceuticals, Inc | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACORAFLOXACIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | ACORAFLOXACIN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | Acorafloxacine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | Acorafloxacino | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | JNJ-32729463 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01198626 ↗ |
| Known as | JNJ-32729463-AAA | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | JNJ-32729463-AAC | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | JNJ-Q2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Known as | Jnj-q2 hydrochloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1257096 ↗ |
| Modality | Small molecule | — CHEMBL1257096 ↗ |
| Route | Oral | “250 mg BID oral dose of JNJ-32729463” NCT01128530 ↗ |